Published in J Exp Med on September 01, 1985
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (1992) 5.07
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest (2006) 3.51
Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A (1992) 2.73
The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med (1988) 2.23
Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A (1995) 2.22
Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol (1998) 2.03
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (2000) 1.96
Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med (1999) 1.92
Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med (1988) 1.89
Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol (2003) 1.81
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology (1992) 1.63
Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther (2005) 1.60
The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology (2001) 1.49
The role of the T cell in autoimmune inflammation. Arthritis Res Ther (2005) 1.46
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest (1996) 1.42
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A (1994) 1.42
Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med (1988) 1.41
Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology (1988) 1.41
Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.26
Genes on the X chromosome affect development of collagen-induced arthritis in mice. Clin Exp Immunol (1993) 1.26
Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (1989) 1.25
Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med (1986) 1.21
IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis (2003) 1.19
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther (2004) 1.15
Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J Exp Med (1993) 1.12
CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol (1994) 1.09
Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Immunology (2004) 1.08
Effect of pregnancy on collagen-induced arthritis in mice. Clin Exp Immunol (1987) 1.08
Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect Immun (1995) 1.08
Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect Immun (1995) 1.03
Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest (1995) 1.02
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol (2004) 1.01
Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin Exp Immunol (1993) 1.01
Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J Clin Immunol (2004) 1.00
CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. J Clin Invest (1994) 1.00
Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. J Clin Invest (1991) 0.99
A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol (1998) 0.98
Synovial lymphocytes and the aetiology of synovitis. Ann Rheum Dis (1993) 0.97
Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1997) 0.96
Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis. Arthritis Res Ther (2008) 0.96
In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis. Immunology (1990) 0.96
CD4+CD25+ regulatory T cells in autoimmune arthritis. Immunol Rev (2010) 0.96
Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1995) 0.93
Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha. Ann Rheum Dis (2000) 0.93
Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PLoS One (2010) 0.92
Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Proc Natl Acad Sci U S A (1989) 0.92
Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin Exp Immunol (1994) 0.92
Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology (2001) 0.91
Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints. Front Immunol (2012) 0.91
Polyclonal Th1 cells transfer oil-induced arthritis. Immunology (1997) 0.90
Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies. J Virol (1989) 0.90
In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clin Exp Immunol (1993) 0.90
Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy. J Exp Med (1999) 0.89
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest (1990) 0.88
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis? Arthritis Res Ther (2005) 0.87
Transfer of type II collagen-induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac-1. Immunology (1996) 0.87
Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin Exp Immunol (1993) 0.85
Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity. Arthritis Res Ther (2006) 0.83
Cardiac allograft survival in mice treated with IL-2-PE40. Proc Natl Acad Sci U S A (1989) 0.82
Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice. Clin Exp Immunol (1993) 0.81
Immunotherapy of rheumatoid arthritis. Ann Rheum Dis (1992) 0.81
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res (2000) 0.80
Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion. Immunology (1998) 0.79
Regulation of cellular and humoral immune responses to collagen type I or collagen type II. Immunology (1988) 0.79
Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. Br J Ophthalmol (1999) 0.78
The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells. Clin Exp Immunol (1994) 0.77
Interleukin-21 signaling in B cells, but not in T cells, is indispensable for the development of collagen-induced arthritis in mice. Arthritis Res Ther (2016) 0.77
Regulation of immunity by anti-T-cell antibodies. West J Med (1990) 0.76
Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells. Immunology (1995) 0.76
Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells. Immunology (1997) 0.75
Premises for immune interventional therapy in rheumatoid arthritis. Postgrad Med J (1988) 0.75
Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev (1979) 16.45
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med (1985) 3.56
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science (1985) 2.68
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Genetic control of the murine T lymphocyte proliferative response to collagen: analysis of the molecular and cellular contributions to immunogenicity. J Immunol (1980) 1.59
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37
mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 8.38
Interacting molecular loops in the mammalian circadian clock. Science (2000) 6.90
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med (1995) 5.18
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (1990) 2.77
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science (1985) 2.68
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med (2001) 2.67
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol (1991) 2.52
Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM (2009) 2.49
In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci U S A (1981) 2.00
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1996) 1.81
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol (1988) 1.72
Post tonsillectomy haemorrhage. J Laryngol Otol (1982) 1.66
A time-less function for mouse timeless. Nat Neurosci (2000) 1.53
Relationship of cesarean delivery to lower birth weight-specific neonatal mortality in singleton breech infants in the United States. Obstet Gynecol (1998) 1.53
Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol (1990) 1.53
In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc Natl Acad Sci U S A (1983) 1.52
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol (1989) 1.40
Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med (1983) 1.37
Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem (1989) 1.32
Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein. J Immunol (1985) 1.31
Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol (1988) 1.26
The relationship between paroxetine and the sparteine oxidation polymorphism. Clin Pharmacol Ther (1992) 1.26
Apoptosis of Fashigh CD4+ synovial T cells by borrelia-reactive Fas-ligand(high) gamma delta T cells in Lyme arthritis. J Exp Med (1996) 1.23
The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. J Immunol (1988) 1.20
Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J Immunol (1982) 1.19
Failure to identify alveolar echinococcosis in trappers from South Dakota in spite of high prevalence of Echinococcus multilocularis in wild canids. J Parasitol (2000) 1.19
Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leukoc Biol (1993) 1.15
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14
Isolation of separate Fc receptors for IgG complexed to antigen and native IgG from a murine leukaemia. Nature (1977) 1.14
Postinfectious and postvaccinial encephalomyelitis. Neurol Clin (1984) 1.13
Studies on the nucleation of monosodium urate at 37 degrees c. Arthritis Rheum (1980) 1.13
Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J Neuroimmunol (1998) 1.12
Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol (1995) 1.12
Osteoarthritis: a review of the cell biology involved and evidence for reversibility. Management rationally related to known genesis and pathophysiology. Semin Arthritis Rheum (1984) 1.11
Molecular defect in a gamma-2 heavy chain. Science (1972) 1.11
Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest (1996) 1.09
T cell development in normal and thymopentin-treated nude mice. J Exp Med (1982) 1.06
Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J Leukoc Biol (1996) 1.06
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology (1996) 1.04
Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci U S A (1991) 1.04
Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-beta in ANA-1 cells. J Leukoc Biol (1998) 1.03
Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol (1993) 1.03
TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol (1998) 1.03
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin (1995) 1.02
Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol (2001) 1.01
Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature (1982) 1.00
Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J Immunol (1999) 0.98
T2D-Db: an integrated platform to study the molecular basis of Type 2 diabetes. BMC Genomics (2008) 0.98
TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J Immunol (1997) 0.98
Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology (2000) 0.98
Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab Invest (1990) 0.97
Sedation for fibre optic bronchoscopy. Respir Med (1995) 0.97
Isolation of a murine leukemia FC receptor by selective release induced by surface redistribution. J Immunol (1976) 0.96
Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur Respir J (1999) 0.96
Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol (1997) 0.96
Chlamydia pneumoniae infection of the central nervous system. Curr Opin Neurol (2001) 0.96
The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation (1988) 0.96
Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors. Eur J Immunol (1994) 0.96
Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J Immunol (1998) 0.96
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Eur J Pharmacol (1988) 0.95
Chloroform extract of Carica papaya seeds induces long-term reversible azoospermia in langur monkey. Asian J Androl (2002) 0.94
Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. J Immunol (1986) 0.93
Anticandidal activity of Santolina chamaecyparissus volatile oil. J Ethnopharmacol (1997) 0.92
Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J mice. Toxicol Appl Pharmacol (1989) 0.92
Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J Neuroimmunol (1993) 0.92
Precision and accuracy of joint space width measurements of the medial compartment of the knee using standardized MTP semi-flexed radiographs. Osteoarthritis Cartilage (2003) 0.92
Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophages. J Exp Med (1980) 0.92
Genomic cloning and heterologous expression of human differentiation-stimulating factor. DNA (1989) 0.91
Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice. Toxicol Appl Pharmacol (1989) 0.91
Allergy to oxidized limonene and linalool is frequent in the U.K. Br J Dermatol (2014) 0.91
Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res (2012) 0.91
Decreased antioxidant enzyme expression and increased oxidative damage in erosive lichen planus of the vulva. BJOG (2005) 0.90
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol (1997) 0.90
Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J Immunol (1987) 0.90
Mixed epithelial stromal tumor of the kidney. Indian J Urol (2011) 0.90
TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol (1995) 0.90
Fc receptors of mouse cell lines. I. Distinct proteins mediate the IgG subclass-specific Fc binding activities of macrophages. J Immunol (1982) 0.89
Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler (2002) 0.89
Photosensitivity reaction associated with use of the combined oral contraceptive. Br J Dermatol (2001) 0.88
Genetic control of tolerance induction to human gamma-globulin in mice. J Immunol (1978) 0.88
Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells. Cell Immunol (1996) 0.88
Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol (1983) 0.88
Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum (1979) 0.88
In vivo immunomodulation by monoclonal anti-L3T4. 1. Effects on humoral and cell-mediated immune response. Cell Immunol (1987) 0.88
Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol (1990) 0.87
Efficacy trial on the purified compounds of the seeds of Carica papaya for male contraception in albino rat. Reprod Toxicol (2005) 0.87
In vivo modulation of murine collagen induced arthritis. Int Rev Immunol (1988) 0.87
A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers. Br J Clin Pharmacol (1990) 0.87
Genetic control of multisystem autoimmune disease in encephalomyocarditis virus infected BALB/cCUM and BALB/cBYJ mice. Curr Top Microbiol Immunol (1985) 0.87
Indirect role of T cells in development of polioencephalitis and encephalomyelitis induced by encephalomyocarditis virus. J Virol (1991) 0.87
Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis. Clin Exp Immunol (1978) 0.87